Therapeutics Letter 132 explores the role of shared decision-making when considering the appropriateness of medication adherence. Conclusions: Non-adherence offers clinicians an opportunity to learn about patient goals and what makes treatment worthwhile for an individual. A shared decision-making framework or structured questioning can facilitate meaningful dialogue and help clinicians understand patient preferences. Informed non-adherence is an acceptable choice compatible with personal autonomy. Documenting patient preferences can improve communication between clinicians and reduce confusion during transitions in care.
Copyright © 1994 - 2022 Therapeutics Initiative, University of British Columbia.